|
|
Volumn 1, Issue , 2009, Pages 6-
|
|
Overview of current and future biologically based targeted therapies in head and neck squamous cell carcinoma.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR;
MAMMALIAN TARGET OF RAPAMYCIN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PROTEIN KINASE INHIBITOR;
PROTEIN SERINE THREONINE KINASE;
SIGNAL PEPTIDE;
VASCULOTROPIN A;
DRUG ANTAGONISM;
HEAD AND NECK TUMOR;
HUMAN;
REVIEW;
SQUAMOUS CELL CARCINOMA;
1-PHOSPHATIDYLINOSITOL 3-KINASE;
CARCINOMA, SQUAMOUS CELL;
HEAD AND NECK NEOPLASMS;
HUMANS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
PROTEIN KINASE INHIBITORS;
PROTEIN-SERINE-THREONINE KINASES;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
|
EID: 68649090008
PISSN: None
EISSN: 17583284
Source Type: Journal
DOI: 10.1186/1758-3284-1-6 Document Type: Review |
|
Times cited : (104)
|
|
References (0)
|
